The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 2926-2938

  Pongratz, Georg ^a   McAlees, Jaclyn W ^a   Conrad, Daniel H ^b   Erbe, Robert S ^a   Haas, Karen M ^c   Sanders, Virginia M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CD19 ANTIGEN; CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN E; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTRANSMITTER; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; FEMALE; IMMUNOGLOBULIN PRODUCTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; UPREGULATION;

EID: 33747769639     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.2926     Document Type: Article

References (83)

1. Burrows, B., F. D. Martinez, M. Halonen, R. A. Barbee, and M. G. Cline. 1989. Association of asthma with serum IgE levels and skin test reactivity to allergens. N. Engl. J. Med. 320: 271-280.
2. Oettgen, H. C., and R. S. Geha. 1999. IgE in asthma and atopy: cellular and molecular connections. J. Clin. Invest. 104: 829-835.
3. Coyle, A. J., K. Wagner, C. Bertrand, S. Tsuyuki, J. Bews, and C. Heusser. 1996. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 183: 1303-1310.
4. Walker, S., M. Monteil, K. Phelan, T. J. Lasserson, and E. H. Walters. 2004. Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst. Rev. CD003559.
5. Hagel, I., M. C. Di Prisco, J. Goldblatt, and P. N. Le Souef. 2004. The role of parasites in genetic susceptibility to allergy: IgE, helminthic infection and allergy, and the evolution of the human immune system. Clin. Rev. Allergy Immunol. 26: 75-83.
6. Kang, H. S., S. E. Blink, R. K. Chin, Y. Lee, O. Kim, J. Weinstock, T. Waldschmidt, D. Conrad, B. Chen, J. Solway, et al. 2003. Lymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation. J. Exp. Med. 198: 1643-1652.
7. Oettgen, H. C. 2000. Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of ε germline transcripts. Curr. Opin. Immunol. 12: 618-623.
8. Chvatchko, Y., M. H. Kosco-Vilbois, S. Herren, J. Lefort, and J. Y. Bonnefoy. 1996. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J. Exp. Med. 184: 2353-2360.
9. Stevens, S., J. Ong, U. Kim, L. A. Eckhardt, and R. G. Roeder. 2000. Role of OCA-B in 3′-IgH enhancer function. J. Immunol. 164: 5306-5312.
10. Tang, H., and P. A. Sharp. 1999. Transcriptional regulation of the murine 3′ IgH enhancer by OCT-2. Immunity 11: 517-526.
11. Grant, P. A., C. B. Thompson, and S. Pettersson. 1995. IgM receptor-mediated transcription of the IgH 3′ enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function. EMBO J. 14: 4501-4513.
12. Sarfati, M., S. Fournier, C. Y. Wu, and G. Delespesse. 1992. Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Immunol. Res. 11: 260-272.
13. Bonnefoy, J. Y., S. Lecoanet-Henchoz, J. F. Gauchat, P. Graber, J. P. Aubry, P. Jeannin, and C. Plater-Zyberk. 1997. Structure and functions of CD23. Int. Rev. Immunol. 16: 113-128.
14. Yu, P., M. Kosco-Vilbois, M. Richards, G. Kohler, and M. C. Lamers. 1994. Negative feedback regulation of IgE synthesis by murine CD23. Nature 369: 753-756.
15. Riffo-Vasquez, Y., D. Spina, M. Thomas, T. Gilbey, D. M. Kemeny, and C. P. Page. 2000. The role of CD23 on allergen-induced IgE levels, pulmonary eosinophilia and bronchial hyperresponsiveness in mice. Clin. Exp. Allergy 30: 728-738.
16. Mayer, R. J., B. J. Bolognese, N. Al-Mahdi, R. M. Cook, P. L. Flamberg, M. J. Hansbury, S. Khandekar, E. Appelbaum, A. Faller, and L. A. Marshall. 2000. Inhibition of CD23 processing correlates with inhibition of IL-4-stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice. Clin. Exp. Allergy 30: 719-727.
17. Saxon, A., Z. Ke, L. Bahati, and R. H. Stevens. 1990. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE. J. Allergy Clin. Immunol. 86: 333-344.
18. Aubry, J. P., S. Pochon, P. Graber, K. U. Jansen, and J. Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358: 505-510.
19. Hibbert, R. G., P. Teriete, G. J. Grandy, R. L. Beavil, R. Reljic, V. M. Holers, J. P. Hannan, B. J. Sutton, H. J. Gould, and J. M. McDonnell. 2005. The structure of human CD23 and its interactions with IgE and CD21. J. Exp. Med. 202: 751-760.
20. Bonnefoy, J. Y., J. F. Gauchat, P. Life, P. Graber, J. P. Aubry, and S. Lecoanet-Henchoz. 1995. Regulation of IgE synthesis by CD23/CD21 interaction. Int. Arch. Allergy Immunol. 107: 40-42.
21. Felten, D. L., S. Y. Felten, D. L. Bellinger, S. L. Carlson, K. D. Ackerman, K. S. Madden, J. A. Olschowki, and S. Livnat. 1987. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 100: 225-260.
22. Felten, S. Y., K. S. Madden, D. L. Bellinger, B. Kruszewska, J. A. Moynihan, and D. L. Felten. 1998. The role of the sympathetic nervous system in the modulation of immune responses. Adv. Pharmacol. 42: 583-587.
23. Cavallotti, C., P. Brazzone, G. Tonnarini, and D. Cavallotti. 2004. Distribution of catecholaminergic neurotransmitters and related receptors in human bronchus-associated lymphoid tissue. Respiration 71: 635-640.
24. Kohm, A. P., and V. M. Sanders. 1999. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J. Immunol. 162: 5299-5308.
25. 2-adrenoceptor agonists and interleukin-4 in the regulation of CD23 expression and release and IgE production in human. Mol. Immunol. 30: 157-164.
26. 2-adrenoceptor agonists. Clin. Exp. Allergy 25: 304-311.
27. 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J. Immunol. 165: 680-690.
28. 2-adrenergic receptor stimulation. J. Immunol. 170: 5143-5151.
29. Kennedy, S. L., M. Nickerson, J. Campisi, J. D. Johnson, T. P. Smith, C. Sharkey, and M. Fleshner. 2005. Splenic norepinephrine depletion following acute stress suppresses in vivo antibody response. J. Neuroimmunol. 165: 150-160.
30. Cross, R. J., J. C. Jackson, W. H. Brooks, D. L. Sparks, W. R. Markesbery, and T. L. Roszman. 1986. Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. Immunology 57: 145-152.
31. + Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow. J. Immunol. 165: 725-733.
32. Kelsoe, G. 1996. The germinal center: a crucible for lymphocyte selection. Semin. Immunol. 8: 179-184.
33. 2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B expression and binding to the 3′-IgH enhancer in B cells. J. Biol. Chem. 279: 23394-23404.
34. Abramson, M. J., J. Walters, and E. H. Walters. 2003. Adverse effects of β-agonists: are they clinically relevant? Am. J. Respir. Med. 2: 287-297.
35. 2- Adrenoceptor agonists up-regulate the in vitro Fc epsilon receptor II/CD23 expression on, and release from, the promonocytic cell line U937 and human blood monocytes. Int. Arch. Allergy Appl. Immunol. 94: 91-92.
36. Haas, K. M., M. Hasegawa, D. A. Steeber, J. C. Poe, M. D. Zabel, C. B. Bock, D. R. Karp, D. E. Briles, J. H. Weis, and T. F. Tedder. 2002. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17: 713-723.
37. Lahn, M., A. Kanehiro, K. Takeda, A. Joetham, J. Schwarze, G. Kohler, R. O'Brien, E. W. Gelfand, and W. Born. 1999. Negative regulation of airway responsiveness that is dependent on γδ T cells and independent of αβ T cells. Nat. Med. 5: 1150-1156.
38. 2-adrenergic receptor intrinsically modulates the level of IgG1 produced per B cell. J. Immunol. 165: 680-690.
39. Payet, M. E., E. C. Woodward, and D. H. Conrad. 1999. Humoral response suppression observed with CD23 transgenics. J. Immunol. 163: 217-223.
40. 2- Adrenoceptor stimulation increases the number of antigen-specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size. J. Immunol. 148: 1822-1828.
41. Czerkinsky, C. C., L.-A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 65: 109-121.
42. Patrone, G., F. Puppo, R. Cusano, M. Scaranari, I. Ceccherini, A. Puliti, and R. Ravazzolo. 2000. Nuclear run-on assay using biotin labeling, magnetic bead capture and analysis by fluorescence-based RT-PCR. BioTechniques 29: 1012-1017.
43. 2-adrenoceptor agonists and interleukin-4 in the regulation of CD23 expression and release and IgE production in human. Mol. Immunol. 30: 157-164.
44. i or Gβγ in adult mouse cardiomyocytes. J. Biol. Chem. 275: 40635-40640.
45. 2 activation. J. Biol. Chem. 276: 39539-39548.
46. Cao, W., A. V. Medvedev, K. W. Daniel, and S. Collins. 2001. β-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J. Biol. Chem. 276: 27077-27082.
47. i-dependent activation. J. Biol. Chem. 275: 19395-19400.
48. i switching. Mol. Pharmacol. 62: 1094-1102.
49. Pesu, M., S. Aittomaki, K. Takaluoma, A. Lagerstedt, and O. Silvennoinen. 2002. p38 mitogen-activated protein kinase regulates interleukin-4-induced gene expression by stimulating STAT6-mediated transcription. J. Biol. Chem. 277: 38254-38261.
50. Marshall, L. A., M. J. Hansbury, B. J. Bolognese, R. J. Gum, P. R. Young, and R. J. Mayer. 1998. Inhibitors of the p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes. J. Immunol. 161: 6005-6013.
51. Craxton, A., G. Shu, J. D. Graves, J. Saklatvala, E. G. Krebs, and E. A. Clark. 1998. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 161: 3225-3236.
52. Brady, K., S. Fitzgerald, S. Ingvarsson, C. A. Borrebaeck, and P. N. Moynagh. 2001. CD40 employs p38 MAP kinase in IgE isotype switching. Biochem. Biophys. Res. Commun. 289: 276-281.
53. Zhang, K., L. Zhang, D. Zhu, D. Bae, A. Nel, and A. Saxon. 2002. CD40-mediated p38 mitogen-activated protein kinase activation is required for immunoglobulin class switch recombination to IgE. J. Allergy Clin. Immunol. 110: 421-428.
54. Fourie, A. M., F. Coles, V. Moreno, and L. Karlsson. 2003. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J. Biol. Chem. 278: 30469-30477.
55. Kim, J., A. D. Eckhart, S. Eguchi, and W. J. Koch. 2002. β-Adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases. J. Biol. Chem. 277: 32116-32123.
56. Matsumoto, A. K., D. R. Martin, R. H. Carter, L. B. Klickstein, J. M. Ahearn, and D. T. Fearon. 1993. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178: 1407-1417.
57. Borish, L., B. Chipps, Y. Deniz, S. Gujrathi, B. Zheng, and C. M. Dolan. 2005. Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. Ann. Allergy. Asthma. Immunol. 95: 247-253.
58. Snapper, C. M., F. D. Finkelman, and W. E. Paul. 1988. Differential regulation of IgG1 and IgE synthesis by interleukin 4. J. Exp. Med. 167: 183-196.
59. Rabah, D., and D. H. Conrad. 2002. Effect of cell density on in vitro mouse immunoglobulin E production. Immunology 106: 503-510.
60. Pinaud, E., A. A. Khamlichi, C. Le Morvan, M. Drouet, V. Nelsso, M. Le Bert, and M. Cogne. 2001. Localization of the 3′ IgH locus elements that effect long-distance regulation of class switching recombination. Immunity 15: 187-199.
61. Snapper, C. M., P. Zelazowski, F. R. Rosas, M. R. Kehry, M. Tian, D. Baltimore, and W. C. Sha. 1996. B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156: 183-191.
62. Bhattacharya, D., D. U. Lee, and W. C. Sha. 2002. Regulation of Ig class switch recombination by NF-κB: retroviral expression of RelB in activated B cells inhibits switching to IgG1, but not to IgE. Int. Immunol. 14: 983-991.
63. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93: 3357-3361.
64. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4: 251-262.
65. Payet, M., and D. H. Conrad. 1999. IgE regulation in CD23 knockout and transgenic mice. Allergy 54: 1125-1129.
66. Payet-Jamroz, M., S. L. Helm, J. Wu, M. Kilmon, M. Fakher, A. Basalp, J. G. Tew, A. K. Szakal, N. Noben-Trauth, and D. H. Conrad. 2001. Suppression of IgE responses in CD23-transgenic animals is due to expression of CD23 on nonlymphoid cells. J. Immunol. 166: 4863-4869.
67. Lecoanet-Henchoz, S., C. Plater-Zyberk, P. Graber, D. Gretener, J. P. Aubry, D. H. Conrad, and J. Y. Bonnefoy. 1997. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18. Eur. J. Immunol. 27: 2290-2294.
68. Christie, G., A. Barton, B. Bolognese, D. R. Buckle, R. M. Cook, M. J. Hansbury, G. P. Harper, L. A. Marshall, M. E. McCord, K. Moulder, et al. 1997. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FceRH). Eur. J. Immunol. 27: 3228-3235.
69. Pene, J., F. Rousset, F. Briere, I. Chretien, J. Wideman, J. Y. Bonnefoy, and J. E. De Vries. 1988. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur. J. Immunol. 18: 929-935.
70. Di Lorenzo, G., A. Drago, M. E. Pellitteri, G. Candore, A. Colombo, M. Potestio, A. Di Salvo, S. Mansueto, and C. Caruso. 1999. Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season. Allergy Asthma Proc. 20: 119-125.
71. Cho, S. W., M. A. Kilmon, E. J. Studer, H. van der Putten, and D. H. Conrad. 1997. B cell activation and Ig, especially IgE, production is inhibited by high CD23 levels in vivo and in vitro. Cell. Immunol. 180: 36-46.
72. Krop, I., A. L. Shaffer, D. T. Fearon, and M. S. Schilssel. 1996. The signaling activity of murine CD19 is regulated during cell development J. Immunol. 157: 48-56.
73. Tedder, T. F., M. Inaoki, and S. Sato. 1997. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6: 107-118.
74. Sato, S., D. A. Steeber, and T. F. Tedder. 1995. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 92: 11558-11562.
75. 2 promotes B lymphocyte Ig isotype switching to IgE. J. Immunol. 154: 162-170.
76. Bauman, G. P., M. M. Bartik, W. H. Brooks, and T. L. Roszman. 1994. Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the β-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell. Immunol. 158: 182-194.
77. Bers, D. M., and M. T. Ziolo. 2001. When is cAMP not cAMP? Effects of compartmentalization. Circ. Res. 89: 373-375.
78. Vila Petroff, M. G., J. M. Egan, X. Wang, and S. J. Sollott. 2001. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ. Res. 89: 445-452.
79. Buxton, I. L., and L. L. Brunton. 1983. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J. Biol. Chem. 258: 10233-10239.
80. 2, forskolin and okadaic acid differentially modulate interleukin-4-versus interleukin-2-dependent immunoglobulin induction in human cellular models, in contrast to other selected modifiers of cellular activation. Int. Arch. Allergy Immunol. 101: 143-152.
81. Marshall, G. D., Jr., and S. K. Agarwal. 2000. Stress, immune regulation, and immunity: applications for asthma. Allergy Asthma Proc. 21: 241-246.
82. Joachim, R. A., D. Quarcoo, P. C. Arck, U. Herz, H. Renz, and B. F. Klapp. 2003. Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom. Med. 65: 811-815.
83. Kvetnansky, R., K. Pacak, K. Fukuhara, E. Viskupic, B. Hiremagalur, B. Nankova, D. S. Goldstein, E. L. Sabban, and I. J. Kopin. 1995. Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann. NY Acad. Sci. 771: 131-158.